Correlating Ic/Pbs Symptoms With Urine Biomarkers

This study has been completed.
Sponsor:
Information provided by:
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00817388
First received: January 5, 2009
Last updated: June 4, 2010
Last verified: June 2010
  Purpose

Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.


Condition Intervention
Interstitial Cystitis
Pelvic Pain
Other: No intervention

Study Type: Observational
Official Title: Correlating Ic/Pbs Symptoms With Urine Biomarkers

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • To correlate IC/PBS symptoms with urine biomarkers [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Urine specimen.


Enrollment: 26
Study Start Date: January 2009
Study Completion Date: May 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
patients will be asked to provide a urine specimen and complete a questionnaire.
Other: No intervention
No intervention

Detailed Description:

The purpose of the study is to improve our understanding of the IC/PBS and develop new treatments. Participation in the study will allow us to compare clinical information, obtained by completion of a brief survey, with substances found in the a urine specimen that is donated to the Beaumont Biobank.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with and without intersitial cystitis/painful pelvic pain will be asked to provide an urine specimen and complete a brief questionnaire.

Criteria

Inclusion:

  1. Men and women with interstitial cystitis/painful bladder syndrome greater than 18 years old
  2. Male and female controls without a history of IC/PBS diagnosis

Exclusion:

1. Unable to complete questionnaires and/or give informed consent

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00817388

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Michael Chancellor, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Michael Chancellor, MD, Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00817388     History of Changes
Other Study ID Numbers: 2008-294
Study First Received: January 5, 2009
Last Updated: June 4, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
Interstitial cystitis
pelvic pain

Additional relevant MeSH terms:
Cystitis
Pelvic Pain
Cystitis, Interstitial
Urinary Bladder Diseases
Urologic Diseases
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on April 17, 2014